Edgardo S. Santos

2.0k total citations
101 papers, 1.2k citations indexed

About

Edgardo S. Santos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Edgardo S. Santos has authored 101 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in Edgardo S. Santos's work include Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Edgardo S. Santos is often cited by papers focused on Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Edgardo S. Santos collaborates with scholars based in United States, Belgium and Italy. Edgardo S. Santos's co-authors include Luis E. Raez, Cesar A. Perez, Christian Rolfo, Michel Velez, Daniel Morgensztern, Estelamari Rodríguez, Christopher O'Brien, Arie Regev, Eloy Roman and Mohamed A. Kharfan‐Dabaja and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Edgardo S. Santos

91 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgardo S. Santos United States 21 576 524 384 230 159 101 1.2k
Morena Fasano Italy 20 680 1.2× 535 1.0× 605 1.6× 244 1.1× 132 0.8× 63 1.4k
Dale R. Shepard United States 17 478 0.8× 470 0.9× 419 1.1× 258 1.1× 95 0.6× 75 1.2k
Véronique D’Hondt France 21 781 1.4× 335 0.6× 298 0.8× 241 1.0× 102 0.6× 83 1.3k
Francisco Javier Ramos Spain 15 625 1.1× 422 0.8× 771 2.0× 192 0.8× 172 1.1× 42 1.4k
Dongmei Ji China 15 539 0.9× 463 0.9× 392 1.0× 130 0.6× 196 1.2× 92 1.2k
Remy B. Verheijen Netherlands 18 630 1.1× 794 1.5× 542 1.4× 182 0.8× 102 0.6× 50 1.4k
Yuankai Shi China 14 547 0.9× 395 0.8× 276 0.7× 104 0.5× 184 1.2× 101 997
Jan Cosaert United States 17 1.1k 1.8× 644 1.2× 438 1.1× 336 1.5× 149 0.9× 43 1.5k
Sophia Abraham United States 8 569 1.0× 491 0.9× 832 2.2× 201 0.9× 108 0.7× 12 1.6k
Martha Donoghue United States 16 696 1.2× 400 0.8× 247 0.6× 285 1.2× 163 1.0× 27 1.2k

Countries citing papers authored by Edgardo S. Santos

Since Specialization
Citations

This map shows the geographic impact of Edgardo S. Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgardo S. Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgardo S. Santos more than expected).

Fields of papers citing papers by Edgardo S. Santos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgardo S. Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgardo S. Santos. The network helps show where Edgardo S. Santos may publish in the future.

Co-authorship network of co-authors of Edgardo S. Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Edgardo S. Santos. A scholar is included among the top collaborators of Edgardo S. Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgardo S. Santos. Edgardo S. Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gandara, David R., Janakiraman Subramanian, Edgardo S. Santos, et al.. (2024). Impact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for Checkpoint Immunotherapy in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 25(6). e252–e261.e4.
2.
Santos, Edgardo S., Thomas K. Oliver, Christina Lacchetti, et al.. (2023). Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments. JCO Oncology Practice. 20(1). 19–32. 5 indexed citations
3.
Schadendorf, Dirk, Reinhard Dummer, Caroline Robert, et al.. (2022). STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future Oncology. 18(17). 2041–2051. 12 indexed citations
4.
Schneider, Bryan J., Nofisat Ismaila, Joachim G.J.V. Aerts, et al.. (2019). Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. Journal of Clinical Oncology. 38(7). 753–766. 105 indexed citations
5.
Gajra, Ajeet, Nagla Abdel Karim, Deborah Mulford, et al.. (2018). nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2. Frontiers in Oncology. 8. 253–253. 10 indexed citations
6.
Corrales, Luis, Amanda Nogueira, Francesco Passiglia, et al.. (2017). Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib. Frontiers in Medicine. 4. 13–13. 16 indexed citations
7.
Santos, Edgardo S., et al.. (2016). Genomic Tissue Analysis and Liquid Biopsy Profiles from Patients Diagnosed with Advanced Adenocarcinoma of the Lung. 1(1). 5 indexed citations
8.
9.
Gitlitz, Barbara J., Eric Bernstein, Edgardo S. Santos, et al.. (2014). A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4). 577–582. 29 indexed citations
10.
Rolfo, Christian, Evelien Smits, Francesco Passiglia, et al.. (2014). Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?. Expert Review of Anticancer Therapy. 14(10). 1173–1187. 22 indexed citations
11.
Velez, Michel, Luis E. Raez, Cesar A. Perez, et al.. (2012). Abnormal elevation of erythrocyte mean corpuscular volume (MCV) in non-small cell lung cancer (NSCLC) patients treated with maintenance pemetrexed-based chemotherapy.. Journal of Clinical Oncology. 30(15_suppl). e17564–e17564. 1 indexed citations
12.
Santos, Edgardo S., et al.. (2012). Epidermal growth factor vaccine in non-small-cell lung cancer. Expert Review of Anticancer Therapy. 12(4). 439–445. 10 indexed citations
13.
Escobar, Mauricio A., et al.. (2011). The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer. BioMed Research International. 2011(1). 806506–806506. 26 indexed citations
14.
Bastos, Bruno R., Georges F. Hatoum, Gail Walker, et al.. (2010). Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(4). 533–539. 15 indexed citations
15.
Perez, Cesar A., et al.. (2010). EGF receptor in lung cancer: a successful story of targeted therapy. Expert Review of Anticancer Therapy. 10(10). 1577–1587. 12 indexed citations
16.
Santos, Edgardo S., Carlos Quintero, Gail Walker, et al.. (2010). Free circulating DNA by RT-PCR as predictor for chemotherapy response in newly diagnosed patients (pts) with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 28(15_suppl). e18107–e18107. 2 indexed citations
17.
18.
Raez, Luis E., Edgardo S. Santos, Gilberto Lopes, et al.. (2006). Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer. 53(3). 347–353. 18 indexed citations
19.
Morgensztern, Daniel, Manuel F. Rosado, Orlando Silva, et al.. (2004). Prevalence of Hepatitis C Infection in Patients with Non-Hodgkin's Lymphoma in South Florida and Review of the Literature. Leukemia & lymphoma. 45(12). 2459–2464. 14 indexed citations
20.
Santos, Edgardo S., et al.. (2003). Primary Hepatic Non-Hodgkin's Lymphomas: Case Report and Review of The Literature. The American Journal of Gastroenterology. 98(12). 2789–2793. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morena Fasano Breakdown of academic impact, for papers by Dale R. Shepard Breakdown of academic impact, for papers by Véronique D’Hondt Breakdown of academic impact, for papers by Francisco Javier Ramos Breakdown of academic impact, for papers by Dongmei Ji Breakdown of academic impact, for papers by Remy B. Verheijen Breakdown of academic impact, for papers by Yuankai Shi Breakdown of academic impact, for papers by Jan Cosaert Breakdown of academic impact, for papers by Sophia Abraham Breakdown of academic impact, for papers by Martha Donoghue
Rankless by CCL
2026